PROVIDER PROFILE · NPI 1659338606
Mandira RayMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,512
Unique beneficiaries
—
Total services
17,756
Distinct HCPCS
44
Medicare payment
$179K
Peer benchmark
Total Medicare services vs. 360 Hematology-Oncology providers in MA — top quintile (cohort median 624).
PRESCRIBING · PART D · 2024
Total Rx claims
772
Beneficiaries
—
Total drug cost
$4.6M
Distinct drugs
20
Brand share
32.6%
Top prescribed drugs
Hydroxyurea75 claims
Lenalidomide67 claims
Abiraterone Acetate64 claims
Ibrutinib61 claims
Prednisone55 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mandira Ray's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA | 48 | 222 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE